Skip to content

Clinical features and genetic variation analysis of cystic fibrosis in children

Clinical features and genetic variation analysis of cystic fibrosis in children

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022196
Enrollment
Unknown
Registered
2019-03-30
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cystic fibrosis

Interventions

CF group + non-CF group:No

Sponsors

Fourth Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.5 Years to 14 Years

Inclusion criteria

Inclusion criteria: Patients aged 6 months to 14 years will be included. Subjects presented with one or more of thefollowing symptoms will be asked to participate in the study: 1 Chronic or recurrent respiratory symptoms, such as: chronic cough, wheezing, increased lung mucus production, nasal polyps,recurrent pneumonia andpersistent chest radiographic abnormalities. 2 Gastrointestinal symptoms, such as:diarrhea,steatorrhea, rectal prolapse, meconium ileus, and hepatobiliarydisease. 3 Growth problem, such as: slow weight gain even with good appetite, failure to thrive with no other diagnosis toexplain their clinical condition.

Exclusion criteria

Exclusion criteria: Children diagnosed with congenital immune defects and genetic metabolic diseases; Parents do not agree to be enrolled for observation, or cannot insist on observation, cannot cooperate with the test.

Design outcomes

Primary

MeasureTime frame
Sweat Chloride;

Countries

China

Contacts

Public ContactHu Xiaohong
xhh304@163.com+86 13911935304

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026